235 related articles for article (PubMed ID: 31226350)
1. Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide.
Yang S; Lee CW; Kim HJ; Jung HH; Kim JI; Shin SY; Shin SH
Peptides; 2019 Aug; 118():170106. PubMed ID: 31226350
[TBL] [Abstract][Full Text] [Related]
2. Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.
Lee EK; Kim YC; Nan YH; Shin SY
Peptides; 2011 Jun; 32(6):1123-30. PubMed ID: 21497177
[TBL] [Abstract][Full Text] [Related]
3. Rationally designed PMAP-23 derivatives with enhanced bactericidal and anticancer activity based on the molecular mechanism of peptide-membrane interactions.
Lee H; Shin SH; Yang S
Amino Acids; 2023 Aug; 55(8):1013-1022. PubMed ID: 37310533
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of free or anchored antimicrobial peptides as candidates for the prevention of orthopaedic device-related infections.
D'Este F; Oro D; Boix-Lemonche G; Tossi A; Skerlavaj B
J Pept Sci; 2017 Oct; 23(10):777-789. PubMed ID: 28707817
[TBL] [Abstract][Full Text] [Related]
5. Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity.
Ahmad A; Azmi S; Srivastava RM; Srivastava S; Pandey BK; Saxena R; Bajpai VK; Ghosh JK
Biochemistry; 2009 Nov; 48(46):10905-17. PubMed ID: 19845398
[TBL] [Abstract][Full Text] [Related]
6. Testing cathelicidin susceptibility of bacterial mastitis isolates: Technical challenges and data output for clinical isolates.
Langer MN; Blodkamp S; Bayerbach M; Feßler AT; de Buhr N; Gutsmann T; Kreienbrock L; Schwarz S; von Köckritz-Blickwede M
Vet Microbiol; 2017 Oct; 210():107-115. PubMed ID: 29103679
[TBL] [Abstract][Full Text] [Related]
7. Differential Abilities of Mammalian Cathelicidins to Inhibit Bacterial Biofilm Formation and Promote Multifaceted Immune Functions of Neutrophils.
Xie F; Zan Y; Zhang X; Zhang H; Jin M; Zhang W; Zhang Y; Liu S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182913
[TBL] [Abstract][Full Text] [Related]
8. Possible role of a PXXP central hinge in the antibacterial activity and membrane interaction of PMAP-23, a member of cathelicidin family.
Yang ST; Jeon JH; Kim Y; Shin SY; Hahm KS; Kim JI
Biochemistry; 2006 Feb; 45(6):1775-84. PubMed ID: 16460024
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients.
Pompilio A; Scocchi M; Pomponio S; Guida F; Di Primio A; Fiscarelli E; Gennaro R; Di Bonaventura G
Peptides; 2011 Sep; 32(9):1807-14. PubMed ID: 21849157
[TBL] [Abstract][Full Text] [Related]
10. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.
Wang G; Epand RF; Mishra B; Lushnikova T; Thomas VC; Bayles KW; Epand RM
Antimicrob Agents Chemother; 2012 Feb; 56(2):845-56. PubMed ID: 22083479
[TBL] [Abstract][Full Text] [Related]
11. Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18.
Haines LR; Thomas JM; Jackson AM; Eyford BA; Razavi M; Watson CN; Gowen B; Hancock RE; Pearson TW
PLoS Negl Trop Dis; 2009; 3(2):e373. PubMed ID: 19190729
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides.
Abraham P; Sundaram A; R A; V R; George S; Kumar KS
PLoS One; 2015; 10(5):e0124210. PubMed ID: 25997127
[TBL] [Abstract][Full Text] [Related]
13. Functional Roles of Aromatic Residues and Helices of Papiliocin in its Antimicrobial and Anti-inflammatory Activities.
Lee E; Kim JK; Jeon D; Jeong KW; Shin A; Kim Y
Sci Rep; 2015 Jul; 5():12048. PubMed ID: 26156126
[TBL] [Abstract][Full Text] [Related]
14. Structure and function of a potent lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide.
Wei L; Yang J; He X; Mo G; Hong J; Yan X; Lin D; Lai R
J Med Chem; 2013 May; 56(9):3546-56. PubMed ID: 23594231
[TBL] [Abstract][Full Text] [Related]
15. Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.
Son M; Lee Y; Hwang H; Hyun S; Yu J
ChemMedChem; 2013 Oct; 8(10):1638-42. PubMed ID: 23894079
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against
Mori T; Yoshida M; Hazekawa M; Ishibashi D; Hatanaka Y; Nagao T; Kakehashi R; Kojima H; Uno R; Ozeki M; Kawasaki I; Yamashita T; Nishikawa J; Uchida T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065861
[TBL] [Abstract][Full Text] [Related]
17. Structural aspects and biological properties of the cathelicidin PMAP-36.
Scocchi M; Zelezetsky I; Benincasa M; Gennaro R; Mazzoli A; Tossi A
FEBS J; 2005 Sep; 272(17):4398-406. PubMed ID: 16128809
[TBL] [Abstract][Full Text] [Related]
18. The cathelicidin-like peptide derived from panda genome is a potential antimicrobial peptide.
Yan X; Zhong J; Liu H; Liu C; Zhang K; Lai R
Gene; 2012 Jan; 492(2):368-74. PubMed ID: 22101189
[TBL] [Abstract][Full Text] [Related]
19. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
[TBL] [Abstract][Full Text] [Related]
20. Structural insight into the mechanism of action of antimicrobial peptide BMAP-28(1-18) and its analogue mutBMAP18.
Agadi N; Vasudevan S; Kumar A
J Struct Biol; 2018 Dec; 204(3):435-448. PubMed ID: 30336202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
